Rodrigo Santos |
Rodrigo Santos is currently the President-Crop Science Division at Bayer AG and a Member at Greater St Louis, Inc. He holds an MBA from The Ohio University and an undergraduate degree from Escola Superior de Agricultura Luiz de Queiroz. |
Norbert Winkeljohann |
Norbert Winkeljohann is currently the Deputy Chairman-Supervisory Board at Deutsche Bank AG since 2022 and the Chairman-Supervisory Board at Bayer AG since 2020. He is also the Chairman-Supervisory Board at Sievert SE, Bohnenkamp AG, and the Co-Managing Director at Sievert Baustoffe GmbH & Co. KG. Additionally, he serves as a Member-Supervisory Board at Georgsmarienhütte Holding GmbH. In his former positions, Dr. Winkeljohann was the Co-Chairman-Supervisory Board at heristo AG from 2018 to 2021. He also held the role of Chairman-Management Board at PricewaterhouseCoopers GmbH Wirtschaftsprüfungsgesellschaft from 2010 to 2018 and at Pwc Europe SE. Wirtschaftspruefungsgesellschaft from 2011 to 2018. Prior to that, he was the Head-Mid-Caps & Family Firms Business Division at PricewaterhouseCoopers AG Wirtschaftsprüfungsgesellschaft from 1999 to 2010. He started his career as an Auditor & Executive Partner at Societâts Treuhand GmbH from 1994 to 1998. He was also a Member-Network Leadership Team at PricewaterhouseCoopers International Ltd. from 2010 to 2018. Dr. Winkeljohann obtained an MBA from the University of Münster in 1983 and a doctorate from the University of Hagen in 1986. |
Bijoy Sagar |
Bijoy Sagar is currently the Director at AI Lean, Inc. and the Chief Information Technology Officer at Bayer AG. Previously, he held positions as the Chief Digital Technology Officer & Vice President at Stryker Corp., the Global Head-Information Systems at Merck KGaA, and the Chief Information Officer at Merck Millipore Corp. He received his undergraduate and graduate degrees from the University of Mumbai. |
Wolfgang U. Nickl |
Wolfgang U. Nickl is currently the Head-Finance at Bayer AG since 2018. Prior to his current position, he served as the Chief Financial Officer & Executive Vice President at ASML Holding NV from 2013 to 2018 and at Western Digital Corp. from 2012 to 2013. He also held the position of Chief Financial Officer at PCG Trading LLC. Mr. Nickl obtained an MBA from USC Marshall School of Business in 2005 and an undergraduate degree from Duale Hochschule Baden-Württemberg Villingen-Schwenningen in 1992. |
William N. Anderson |
William N. Anderson is currently the Chief Executive Officer at Bayer AG since 2023. He is also serving as the Director at Chugai Pharmaceutical Co., Ltd. since 2019 and as a Director at Pharmaceutical Research & Manufacturers of America. Previously, he held the position of Chief Executive Officer & Director at Genentech, Inc. He was also the Chief Executive Officer at Roche Pharmaceuticals, Inc. from 2019 to 2022 and at Roche Pharma (Schweiz) AG from 2019 to 2023. Prior to that, he worked as the Vice President-Neurology Unit at Biogen, Inc. from 2004 to 2006. Mr. Anderson completed his graduate degree from Massachusetts Institute of Technology and his undergraduate degree from The University of Texas at Austin. |
Christian Rommel |
Christian Rommel's current jobs include being a Director at Asklepios BioPharmaceutical, Inc., a Director at Vividion Therapeutics, Inc., a Director at CRISPR Therapeutics AG, and EVP, Head-Research & Development at Bayer AG. Dr. Rommel's former jobs include being a Senior Scientist at Regeneron Pharmaceuticals, Inc., Chief Scientific Officer at Intellikine LLC from 2007 to 2012, Head-Target Research at Merck Serono Ltd., and VP-External Research & Development at Amgen, Inc. He was also SVP, Head-Oncology Research & Early Development at F. Hoffmann-La Roche Ltd. from 2018 to 2021. Dr. Rommel obtained a doctorate degree from Max-Planck-Institute for Molecular Genetics and an undergraduate degree from the University of Greifswald. |
Philipp Blank |
Philipp Blank currently works at Bayer AG, as Head-Law, Compliance & Information Technology. |
Stefan Oelrich |
Stefan Oelrich is currently the Director at Vividion Therapeutics, Inc. He is also the President-Pharmaceuticals Division at Bayer AG and a Member of the Management Board at the American Chamber of Commerce in Germany eV. Additionally, he serves as an Advisor at Longwood Fund Management LLC and is a Member of the Supervisory Board at the Berlin Institute of Health and Charité - Universitätsmedizin Berlin. Formerly, Mr. Oelrich worked at Sanofi as the Executive VP-Diabetes & Cardiovascular from 2011 to 2018. He also held a position as Senior Vice President & General Manager at Women's Healthcare. |
Julio Triana |
Julio Triana is currently the President at Bayer Holding Ltd. He is also the President-Consumer Health Division at Bayer AG since 2002 and the Head-Commercial Operations Region at Bayer Pharmaceuticals since 2016. Previously, he worked as the Chief Transformation Officer at Bayer Yakuhin Ltd. Mr. Triana completed his undergraduate degree at the University of Houston and holds an MBA from Nebrija University. |